Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® in Healthy Volunteers and in Patients With Liver Disease

NCT01420211 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.

NCT NCT01420211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01420211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® in Healthy Volunteers and in Patients With Liver Disease
Lead sponsor
University Medicine Greifswald
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2010
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug transporter, gd-eob-dtpa, liver, mri, pharmacokinetics